Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PD-L1 CAR-T in Advanced NSCLC
NCT03330834Phase 1Terminated
- Sponsor
- Sun Yat-sen University
- Start
- Nov 2017
- Primary completion
- Apr 2020
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of PD-L1 CAR-T cells in non-small cell lung cancer (NSCLC), sponsored by Sun Yat-sen University. Primary endpoint: Number of Participants With Treatment-Emergent Adverse Events Associated With PD-L1 CAR-T Cell Treatment at 2 years. Started Nov 2017; status: terminated.
02
Drugs
PD-L1 CAR-T cells
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03330834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03330834.